Cybin IncChange company Symbol lookupSelect an option...CYBN Cybin IncOTCM OTC Markets Group IncLCII LCI IndustriesCOF-K Capital One Financial CorpESI Element Solutions IncSTXB Spirit of Texas Bancshares IncED Consolidated Edison IncSNAP Snap IncTHQ Tekla Healthcare Opportunities FundTGIOY Tung Ho Steel Enterprise CorpGo
Based in Canada
Cybin Inc., formerly Clarmin Explorations Inc., is a Canada-based life sciences company. The Company is focused on developing psychedelic pharmaceutical and non-psychedelic nutraceutical-based products. Its subsidiaries include Natures Journey Inc. and Serenity Life Sciences Inc. Serenity Life Sciences Inc. is focused on research and development of psilocybin-based medications. Natures Journey Inc. operates the Journey brand, which specializes in developing medicinal mushroom products. It has a drug delivery platform developed to administer psychedelic therapies and bypass liver metabolism. The Company also focus is on the development of treatment regimens consisting of psychedelic molecules and related clinical protocols.
Postmarket |
|
|
| ||
Market Hours |
|
|
|
|
|
Upcoming Events
Past Stock Splits
| Date | Event description | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| November 10, 2020 | 1:6.672 Stock Split | |||||||||
Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.
, , , Copyright © 2021. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.